Armistice Capital’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,565,577
Closed -$79.9M 291
2024
Q4
$79.9M Sell
1,565,577
-256,423
-14% -$12.6M 1.09% 14
2024
Q3
$75.1M Buy
1,822,000
+812,748
+81% +$39M 1.2% 13
2024
Q2
$48.6M Buy
1,009,252
+786,501
+353% +$34.9M 0.61% 28
2024
Q1
$10.7M Buy
222,751
+176,429
+381% +$9.42M 0.14% 97
2023
Q4
$3.01M Sell
46,322
-54,410
-54% -$3.28M 0.04% 138
2023
Q3
$6.59M Sell
100,732
-87,268
-46% -$5.49M 0.1% 104
2023
Q2
$10.9M Buy
188,000
+52,000
+38% +$3.28M 0.16% 88
2023
Q1
$8.4M Buy
+136,000
New +$8.16M 0.12% 97

Other funds holding NARI

Armistice Capital's NARI Position: Q1 2025 in Review

Armistice Capital sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 1,565,577 shares — an estimated $79.9M sold.

Armistice Capital first reported a position in NARI in Q1 2023 and held it in 8 quarters. The position peaked at $79.9M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Armistice Capital reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Armistice Capital sold 1,565,577 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $79.9M.
  • Armistice Capital first reported a position in Inari Medical, Inc. Common Stock in Q1 2023 and held it in 8 quarters.
  • Armistice Capital's Inari Medical, Inc. Common Stock position peaked at $79.9M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.